Clinical Trial Results:
            The Efficacy and Safety of Intra-Arterial Administration of REX-001 to Treat Ischaemic Ulcers in Subjects with Critical Limb Ischaemia Rutherford Category 5 and Diabetes Mellitus: A Pivotal, Placebo-Controlled, Double-Blind, Parallel-Group, Adaptive Trial
    
| 
                 Summary 
         | 
        |
    EudraCT number  | 
        2016-003980-21 | 
    Trial protocol  | 
        DE ES AT NL HU PL CZ PT GB LV LT | 
    Global completion date  | 
        |
| 
                 Paediatric regulatory details 
         | 
        |
    Is the trial part of an agreed EMA paediatric investigation plan?  | 
        |
    Is the trial in scope of article 45 of Regulation (EC) No 1901/2006?  | 
        |
    Is the trial in scope of article 46 of Regulation (EC) No 1901/2006?  | 
        |
| 
                 Results information 
         | 
        |
    Results version number  | 
        v1(current) | 
    This version publication date  | 
        
                                    06 Jul 2023
                             
         | 
    
    First version publication date  | 
        
                                    06 Jul 2023
                             
         | 
    
    Other versions  | 
        |
    Summary report(s)  | 
                                REX-001-005 CSR | 
    
            Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to            Commission Guideline 2012/C 302/03
            for further information.